Anemia: Research & News
- Pretreatment Anemia Raises Mortality Risk Among HCV/HIV Coinfected Patients (May 9, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients (August 2005)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- HIV/AIDS Anemia: Prevalence and Severity of Anemia Increases With Advancing HIV Disease (July 14, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Early Diagnosis and Appropriate Treatment of HIV-Related Anemia Important to Survival of the HIV-Positive (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Mild to Moderate Anemia Remains Common in HIV Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Counterfeit Procrit Alert (March 12, 2003)
From U.S. Food and Drug Administration
- Zidovudine-Related Anemia With Reticulocytosis (March 2003)
In Annals of Hematology
- Greater Prevalence of Anemia in Women and African Americans With HIV/AIDS in the HAART Era: A Study of 10,000 Patients (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Once-Weekly Epoetin Alfa Corrects Hemoglobin and Improves Quality of Life as Effectively as Three-Times Weekly Dosing in HIV-Positive Patients (July 11, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Important Drug Warning: Counterfeiting of Procrit (June 7, 2002)
To read PDF, click here.
From U.S. Food and Drug Administration
- Important Drug Warning: Counterfeiting of Epogen (May 8, 2002)
From U.S. Food and Drug Administration
- Once-Weekly Dosing of 40,000 U Epoetin Alpha Is as Effective as Thrice-Weekly Dosing Among HIV-Positive Patients (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from TheBodyPRO.com
- Anemia Symposium Discusses Relationship With HIV, Cancer, Hepatitis C; Discusses Erythropoietin Use (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from TheBodyPRO.com
- HIV-Associated Hematologic Disorders Are Correlated With Plasma Viral Load and Improve Under Highly Active Antiretroviral Therapy (November 2001)
In Journal of Acquired Immune Deficiency Syndromes
- Treatment of Anemia in Patients With HIV Infection, Part 1: The Need for Adequate Guidelines (November/December 2001)
In Journal -- Association of Nurses in AIDS Care
- Once-Weekly Epoetin Alfa Increases Hemoglobin and Improves Quality of Life in Anemic HIV-Positive Patients (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Prevalence and Cumulative Incidence of and Risk Factors for Anemia in a Multicenter Cohort Study of Human Immunodeficiency Virus -- Infected and Uninfected Women (August 7, 2001)
In Clinical Infectious Diseases
- A Case-Control Study to Examine the Association of HIV/AIDS Progression With the Development and Treatment of Anemia: Results From the 1996 Enrollment Cohort (July 9, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Anemia More Prevalent in Women and African Americans With HIV/AIDS (July 9, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy (April 2001)
In Journal of Acquired Immune Deficiency Syndromes
|
Advertisement
|
Email
Glossary
